Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use* / Q000031:analogs & derivatives; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008747:Methylcellulose / Q000031:analogs & derivatives*; D010212:Papilloma / Q000188:drug therapy* / Q000556:secondary; D010455:Peptides / Q000627:therapeutic use*; D011070:Poly I-C / Q000627:therapeutic use*; D011107:Polylysine / Q000627:therapeutic use* / Q000031:analogs & derivatives
D007369:Interferon Inducers; D010455:Peptides; D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C